3rd Treg Directed Therapies Summit

Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale. URLs: Brochure: https:go.evvnt.com710471-0?pid1774...
Medicine and Me... Medicine and M...
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale. URLs: Brochure: https:go.evvnt.com710471-0?pid1774 Tickets: https:go.evvnt.com710471-1?pid1774 Prices: Drug Developers Earlybird rates and workshops available: USD 2099.0, Academic Earlybird rates and workshops available: USD 1899.0, Service Providers Earlybird rates and workshops available: USD 2599.0 Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics, Wenjun Ouyang, Executive Director, Amgen Inc, Francisco Ramirez-Valle, Executive Director, Bristol-Myers Squibb Time: 09:00 - 17:30
info@hansonwade.com
Online, Online, United States of America